Julie Hanson Ostrander

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status
    Julie Hanson Ostrander
    Department of Medicine, Division of Medical Oncology, Duke University Medical Center and Department of Biomedical Engineering, Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27710, USA
    Cancer Res 70:4759-66. 2010
  2. ncbi Light scattering measurements of subcellular structure provide noninvasive early detection of chemotherapy-induced apoptosis
    Kevin J Chalut
    Department of Biomedical Engineering, Fitzpatrick Institute for Photonics, Duke University, Durham, North Carolina 27708, USA
    Cancer Res 69:1199-204. 2009
  3. ncbi Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells
    Julie Hanson Ostrander
    Department of Medicine, University of Minnesota Cancer Center, Minneapolis, Minnesota 55455, USA
    Cancer Res 67:4199-209. 2007

Detail Information

Publications3

  1. ncbi Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status
    Julie Hanson Ostrander
    Department of Medicine, Division of Medical Oncology, Duke University Medical Center and Department of Biomedical Engineering, Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27710, USA
    Cancer Res 70:4759-66. 2010
    ..This source of optical contrast could be a potentially useful tool for drug screening in preclinical models...
  2. ncbi Light scattering measurements of subcellular structure provide noninvasive early detection of chemotherapy-induced apoptosis
    Kevin J Chalut
    Department of Biomedical Engineering, Fitzpatrick Institute for Photonics, Duke University, Durham, North Carolina 27708, USA
    Cancer Res 69:1199-204. 2009
    ..These results suggest that a/LCI may have utility in detecting early apoptotic events for both clinical and basic science applications...
  3. ncbi Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells
    Julie Hanson Ostrander
    Department of Medicine, University of Minnesota Cancer Center, Minneapolis, Minnesota 55455, USA
    Cancer Res 67:4199-209. 2007
    ..These results place Brk in a novel signaling pathway downstream of ErbB receptors and upstream of Rac, p38 MAPK, and ERK5 and establish the ErbB-Brk-Rac-p38 MAPK pathway as a critical mediator of breast cancer cell migration...